| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:39 UTC |
|---|
| HMDB ID | HMDB0014511 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Levonorgestrel |
|---|
| Description | Levonorgestrel, also known as microlut or norplant, belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. Thus, levonorgestrel is considered to be a steroid lipid molecule. Levonorgestrel is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Levonorgestrel is a potentially toxic compound. |
|---|
| Structure | [H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one | ChEBI | | 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one | ChEBI | | 13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one | ChEBI | | 13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one | ChEBI | | 17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one | ChEBI | | 17-alpha-Ethynyl-13-ethyl-19-nortestosterone | ChEBI | | 17-Ethynyl-18-methyl-19-nortestosterone | ChEBI | | 17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol | ChEBI | | 17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one | ChEBI | | 17alpha-Ethynyl-18-homo-19-nortestosterone | ChEBI | | 18-Methyl-17-alpha-ethynyl-19-nortestosterone | ChEBI | | 18-Methylnorethisterone | ChEBI | | D(-)-Norgestrel | ChEBI | | Jadelle | ChEBI | | Levonelle | ChEBI | | Levonorgestrelum | ChEBI | | Levonova | ChEBI | | Microlut | ChEBI | | Microluton | ChEBI | | Microval | ChEBI | | Mirena | ChEBI | | NorLevo | ChEBI | | Plan b | ChEBI | | Postinor | ChEBI | | (+-)-Norgestrel | Kegg | | Ovrette | Kegg | | (-)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one | Generator | | (-)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one | Generator | | 13-b-Ethyl-17a-ethynyl-17b-hydroxygon-4-en-3-one | Generator | | 13-Β-ethyl-17α-ethynyl-17β-hydroxygon-4-en-3-one | Generator | | 13-Ethyl-17-a-ethynyl-17-b-hydroxy-4-gonen-3-one | Generator | | 13-Ethyl-17-α-ethynyl-17-β-hydroxy-4-gonen-3-one | Generator | | 13-Ethyl-17-a-ethynylgon-4-en-17-b-ol-3-one | Generator | | 13-Ethyl-17-α-ethynylgon-4-en-17-β-ol-3-one | Generator | | 17-a-Ethinyl-13-b-ethyl-17-b-hydroxy-4-estren-3-one | Generator | | 17-Α-ethinyl-13-β-ethyl-17-β-hydroxy-4-estren-3-one | Generator | | 17-a-Ethynyl-13-ethyl-19-nortestosterone | Generator | | 17-Α-ethynyl-13-ethyl-19-nortestosterone | Generator | | 17a-Ethynyl-13b-ethyl-3-oxo-4-estren-17b-ol | Generator | | 17Α-ethynyl-13β-ethyl-3-oxo-4-estren-17β-ol | Generator | | 17a-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one | Generator | | 17Α-ethynyl-17-hydroxy-18-methylestr-4-en-3-one | Generator | | 17a-Ethynyl-18-homo-19-nortestosterone | Generator | | 17Α-ethynyl-18-homo-19-nortestosterone | Generator | | 18-Methyl-17-a-ethynyl-19-nortestosterone | Generator | | 18-Methyl-17-α-ethynyl-19-nortestosterone | Generator | | Levonorgestrel alcala brand | HMDB | | Levonorgestrel hexal brand | HMDB | | Norplant | HMDB | | Paladin brand OF levonorgestrel | HMDB | | Vikela | HMDB | | Wyeth brand OF levonorgestrel | HMDB | | Duofem | HMDB | | L-Norgestrel | HMDB | | Aventis pharma brand OF levonorgestrel | HMDB | | Berlex brand OF levonorgestrel | HMDB | | HRA brand 1 OF levonorgestrel | HMDB | | Hexal brand OF levonorgestrel | HMDB | | Levonorgestrel paladin brand | HMDB | | Levonorgestrel wyeth brand | HMDB | | Norplant 2 | HMDB | | Alcala brand OF levonorgestrel | HMDB | | Capronor | HMDB | | Cerazet | HMDB | | D-Norgestrel | HMDB | | HRA brand 2 OF levonorgestrel | HMDB | | Norplant-2 | HMDB | | Schering brand 3 OF levonorgestrel | HMDB | | L Norgestrel | HMDB | | D Norgestrel | HMDB | | Levonorgestrel berlex brand | HMDB | | Norgeston | HMDB | | Norplant2 | HMDB | | Schering brand 1 OF levonorgestrel | HMDB | | Schering brand 2 OF levonorgestrel | HMDB | | Women's capital brand OF levonorgestrel | HMDB | | Levonorgestrel | MeSH |
|
|---|
| Chemical Formula | C21H28O2 |
|---|
| Average Molecular Weight | 312.4458 |
|---|
| Monoisotopic Molecular Weight | 312.20893014 |
|---|
| IUPAC Name | (1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
|---|
| Traditional Name | (1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
|---|
| CAS Registry Number | 797-63-7 |
|---|
| SMILES | [H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] |
|---|
| InChI Identifier | InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1 |
|---|
| InChI Key | WWYNJERNGUHSAO-XUDSTZEESA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Estrane steroids |
|---|
| Direct Parent | Estrogens and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Estrogen-skeleton
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- 17-hydroxysteroid
- Oxosteroid
- Hydroxysteroid
- Delta-4-steroid
- Cyclohexenone
- Ynone
- Cyclic alcohol
- Tertiary alcohol
- Cyclic ketone
- Ketone
- Acetylide
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Alcohol
- Organooxygen compound
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | - terminal acetylenic compound (CHEBI:6443 )
- 3-oxo Delta(4)-steroid (CHEBI:6443 )
- 17beta-hydroxy steroid (CHEBI:6443 )
- Pregnane and derivatives [Fig] (C08153 )
- C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives (C08153 )
- C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives (LMST02030119 )
|
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 240 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0058 g/L | Not Available | | LogP | 3.8 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.6 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 16.7629 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.18 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2577.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 423.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 210.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 198.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 469.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 804.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 751.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 92.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1460.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 473.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1485.0 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 477.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 435.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 291.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 497.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 15.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Levonorgestrel,1TMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC | 2867.1 | Semi standard non polar | 33892256 | | Levonorgestrel,1TMS,isomer #2 | C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 2760.1 | Semi standard non polar | 33892256 | | Levonorgestrel,2TMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 2837.5 | Semi standard non polar | 33892256 | | Levonorgestrel,2TMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 2914.3 | Standard non polar | 33892256 | | Levonorgestrel,2TMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 3258.3 | Standard polar | 33892256 | | Levonorgestrel,1TBDMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC | 3128.6 | Semi standard non polar | 33892256 | | Levonorgestrel,1TBDMS,isomer #2 | C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 3025.5 | Semi standard non polar | 33892256 | | Levonorgestrel,2TBDMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 3345.5 | Semi standard non polar | 33892256 | | Levonorgestrel,2TBDMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 3383.2 | Standard non polar | 33892256 | | Levonorgestrel,2TBDMS,isomer #1 | C#C[C@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@@H]4[C@H]3CC[C@@]21CC | 3436.9 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Levonorgestrel GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-0490000000-497c4ebd506c0b9c8ec3 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Levonorgestrel GC-MS (1 TMS) - 70eV, Positive | splash10-0a4l-1259000000-2a7acf9f8fd01faadc86 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Levonorgestrel GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel LC-ESI-qTof , Positive-QTOF | splash10-066r-0931000000-4a863e895a5edd6cebeb | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel , positive-QTOF | splash10-03di-0439000000-bcbc7c657a115dced40a | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel , positive-QTOF | splash10-0a5a-3920000000-edbd3785e7d20d9e81be | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel , positive-QTOF | splash10-0a4i-2920000000-a08b14b6d762cf4c42b1 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel 45V, Negative-QTOF | splash10-0002-0900000000-ccbe00eb6d33f44bf13e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel 30V, Negative-QTOF | splash10-03dj-0809000000-3b4f03aa1582c55a88a4 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel 45V, Positive-QTOF | splash10-0a59-2910000000-2e210ea979850c3d19ac | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel 90V, Negative-QTOF | splash10-0002-0900000000-87a5333787ffe2461b52 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel 30V, Positive-QTOF | splash10-03dj-1943000000-e4eeb86036aa8456827f | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel 35V, Positive-QTOF | splash10-06r2-0932000000-542d94c4f65730336be8 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel 75V, Negative-QTOF | splash10-0002-0900000000-d9c9cc75f7d652292590 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel 60V, Negative-QTOF | splash10-0002-0900000000-a5a5bd10465f22e61a65 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel 15V, Positive-QTOF | splash10-03di-0009000000-0d184562b2bcf62fab5c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel 75V, Positive-QTOF | splash10-055f-7900000000-2c2242a1883d4b23fb14 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel 60V, Positive-QTOF | splash10-0a5c-4900000000-64d2115a1e9554b15780 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel 90V, Positive-QTOF | splash10-05po-9700000000-f172af0f505e7230dfcc | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Levonorgestrel 15V, Negative-QTOF | splash10-03di-0009000000-73765d8e0531c2c94251 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Levonorgestrel 10V, Positive-QTOF | splash10-03di-0179000000-09f92950350c9411f4dc | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Levonorgestrel 20V, Positive-QTOF | splash10-0btj-0191000000-7bd7256abde150b22d9f | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Levonorgestrel 40V, Positive-QTOF | splash10-0f76-2390000000-84a923da67ade6ef90a8 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Levonorgestrel 10V, Negative-QTOF | splash10-03di-0019000000-3f0cb0e2e76214741c6f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Levonorgestrel 20V, Negative-QTOF | splash10-03di-0059000000-f6e5c83ac4c0da584cb2 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Levonorgestrel 40V, Negative-QTOF | splash10-053v-0090000000-6bb0ea8f0fc81b4c6fe2 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Levonorgestrel 10V, Negative-QTOF | splash10-03di-0009000000-152b659b4891e36b54f3 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Levonorgestrel 20V, Negative-QTOF | splash10-03di-0019000000-51b6ec5de157050ca35e | 2021-09-22 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
|
|---|